Literature DB >> 21594943

Evaluation of allergens in propolis by ultra-performance liquid chromatography/tandem mass spectrometry.

Claudio Gardana1, Paolo Simonetti.   

Abstract

The purified extract of propolis is used as a traditional remedy for the treatment of several diseases. Its beneficial activities are mainly attributed to the polyphenolic fraction. Nevertheless, propolis can cause allergic dermatitis and the sensitization rate in humans is increasing significantly mainly in younger subjects. The aim of this study was to develop and validate a selective and sensitive ultra-performance liquid chromatography tandem mass spectrometry analysis (UPLC/MS/MS) for the evaluation of the amount of caffeic acid and its esters with allergenic action in raw propolis samples and commercial formulations. The separation was carried out on a 1.7 μm C(18) BEH Shield column and the detection performed by means of electrospray ionization in negative ion mode with multiple reaction monitoring. The confirmation of formulae of the precursor and product ions was accomplished by injection into a high-resolution system (FTICR-MS) using accurate mass measurements. The error was below 1.4 ppm.The range of the standard curves was 0.5-10 μg/mL and dihydrocaffeic acid was used as internal standard (IS). The lower limit of detection (LLOD) for 3-methyl-2-butenyl-(3M2B), 3-methyl-3-butenyl-(3M3B), 2-methyl-2-butenyl-(2M2B), benzyl-(CABE), phenylethylcaffeic acid (CAPE) and for caffeic acid (CA) and the IS was 0.1 and 0.3 μg/mL, respectively. The recoveries were in the range 96-104% and the intra- and inter-day precisions were within 6.2%. In the European (n=8) and Asiatic (n=3) propolis the most abundant allergens were CABE>3M2B>CAPE>3M3B>CA>2M2B. These compounds were not found in the red (n=1) and green (n=1) Brazilian propolis. Hydroalcoholic extracts (n=6) and tablets (n=6) were analyzed by the proposed UPLC/MS/MS method. The results showed that in the commercial products CABE, 3M2B, CAPE and 3M3B were also the most abundant.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594943     DOI: 10.1002/rcm.5025

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study.

Authors:  Takuya Fukuda; Michiaki Fukui; Muhei Tanaka; Takafumi Senmaru; Hiroya Iwase; Masahiro Yamazaki; Wataru Aoi; Toshio Inui; Naoto Nakamura; Yoshinori Marunaka
Journal:  Biomed Rep       Date:  2015-02-25

2.  Biotransformation strategy to reduce allergens in propolis.

Authors:  Claudio Gardana; Andrea Barbieri; Paolo Simonetti; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2012-04-20       Impact factor: 4.792

3.  Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic.

Authors:  Flavia F Veiga; Marina C Gadelha; Marielen R T da Silva; Maiara I Costa; Brenda Kischkel; Lidiane V de Castro-Hoshino; Francielle Sato; Mauro L Baesso; Morgana F Voidaleski; Vanessa Vasconcellos-Pontello; Vânia A Vicente; Marcos L Bruschi; Melyssa Negri; Terezinha I E Svidzinski
Journal:  Front Microbiol       Date:  2018-04-25       Impact factor: 5.640

4.  Propolis and allergic reactions.

Authors:  Nandini D Basavaiah; Deepak B Suryakanth
Journal:  J Pharm Bioallied Sci       Date:  2012-10

5.  [Propolis: origin, composition and properties].

Authors:  N Cardinault; M-O Cayeux; P Percie du Sert
Journal:  Phytotherapie (Paris)       Date:  2012-10-08

6.  Evaluation of the Skin-Sensitizing Potential of Brazilian Green Propolis.

Authors:  Erina Shiraishi; Keishi Ishida; Daisuke Matsumaru; Akiko Ido; Youhei Hiromori; Hisamitsu Nagase; Tsuyoshi Nakanishi
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.